We are live on ! Find out more
LPCN icon

Lipocine
LPCN

17 hedge funds and large institutions have $23.7M invested in Lipocine in 2014 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

20% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 5

7% more capital invested

Capital invested by funds: $22.2M → $23.7M (+$1.49M)

6% more funds holding

Funds holding: 16 → 17 (+1)

Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
VAM
Visium Asset Management
New York
+$8.82M
2
VM
VHCP Management
New York
+$3.86M
3
GTC
Ghost Tree Capital
New York
+$671K
4
Millennium Management
Millennium Management
New York
+$645K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$389K

Top Sellers

1
JHIU
Janus Henderson Investors US
Colorado
-$3.92M
2
TCP
Tourbillon Capital Partners
New York
-$2.75M
3
SM
Sabby Management
Florida
-$2.54M
4
BC
Broadfin Capital
New York
-$1.61M
5
WC
Wexford Capital
Florida
-$1.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
VAM
1
Visium Asset Management
New York
$7.37M +$8.82M +70,941 New
VM
2
VHCP Management
New York
$4.09M +$3.86M +31,048 +371%
BBA
3
Baker Bros. Advisors
New York
$3.06M – – –
LOAMU
4
Lombard Odier Asset Management (USA)
New York
$2.44M +$73.1K +588 +3%
DMAM
5
Del Mar Asset Management
New York
$2.02M -$19.4K -156 -0.8%
JHIU
6
Janus Henderson Investors US
Colorado
$1.87M -$3.92M -31,553 -64%
Millennium Management
7
Millennium Management
New York
$611K +$645K +5,188 +748%
GTC
8
Ghost Tree Capital
New York
$561K +$671K +5,398 New
PCM
9
Prelude Capital Management
New York
$421K +$59.4K +478 +13%
Vanguard Group
10
Vanguard Group
Pennsylvania
$325K +$389K +3,130 New
ISL
11
Ingalls & Snyder LLC
New York
$292K +$58.8K +473 +20%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$291K +$349K +2,809 New
Goldman Sachs
13
Goldman Sachs
New York
$162K +$193K +1,555 New
VKH
14
Virtu KCG Holdings
New York
$162K +$197K +1,581 New
LTFS
15
Ladenburg Thalmann Financial Services
Florida
$12K +$7.33K +59 +100%
BIM
16
BlackRock Investment Management
Delaware
$10K +$249 +2 +2%
TCP
17
Tourbillon Capital Partners
New York
– -$2.75M -26,471 Closed
SM
18
Sabby Management
Florida
– -$2.54M -24,512 Closed
BC
19
Broadfin Capital
New York
– -$1.61M -15,561 Closed
WC
20
Wexford Capital
Florida
– -$1.14M -10,941 Closed
TRCT
21
Tower Research Capital (TRC)
New York
– -$5K -51 Closed

LPCN Hedge Fund Activity: Q3 2014 in Review

17 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Lipocine (LPCN) for Q3 2014, worth a combined $23.7M — up 6.7% from $22.2M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new LPCN positions and 5 closed out — a net gain of 1 holder — while 7 added to existing stakes and 2 trimmed.

The largest buyer was Visium Asset Management, opening a new position worth an estimated $8.82M. The largest seller was Janus Henderson Investors US, cutting an estimated $3.92M.

  • 17 institutional investors held Lipocine (LPCN) as of Q3 2014, up from 16 in Q2 2014.
  • Funds reported $23.7M of Lipocine stock for Q3 2014, up 6.7% quarter-over-quarter.
  • 6 funds opened new Lipocine positions in Q3 2014 and 5 closed out, a net change of +1 holder.
  • The largest Lipocine buyer in Q3 2014 was Visium Asset Management, an estimated $8.82M added.
  • The largest Lipocine seller in Q3 2014 was Janus Henderson Investors US, an estimated $3.92M sold.

Based on aggregated 13F filings for Q3 2014.